Kremer B - Search Results

1

Efficient dose-dependent and time-dependent protein transduction of pancreatic carcinoma cells in vitro and in vivo using purified VP22-EGFP fusion protein.

Boenicke L, Chu K, Pauls R, Tams C, Kruse ML, Kurdow R, Schniewind B, Böhle A, Kremer B, Kalthoff H. Boenicke L, et al. Among authors: kremer b. J Mol Med (Berl). 2003 Mar;81(3):205-13. doi: 10.1007/s00109-003-0421-3. Epub 2003 Mar 18. J Mol Med (Berl). 2003. PMID: 12682729

2

Adjuvant treatment of pancreatic carcinoma in a clinically adapted mouse resection model.

Tepel J, Kruse ML, Kapischke M, Haye S, Sipos B, Kremer B, Kalthoff H. Tepel J, et al. Among authors: kremer b. Pancreatology. 2006;6(3):240-7. doi: 10.1159/000092027. Epub 2006 Mar 15. Pancreatology. 2006. PMID: 16543775

3

A modified random oligonucleotide-based combination therapy for adjuvant treatment of pancreatic ductal adenocarcinoma.

Tepel J, March C, Ketterer T, Kapischke M, Arlt A, Kremer B, Kalthoff H, Kruse ML. Tepel J, et al. Among authors: kremer b. Int J Oncol. 2006 May;28(5):1105-12. Int J Oncol. 2006. PMID: 16596226

4

Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma.

Vogel I, Kalthoff H, Henne-Bruns D, Kremer B. Vogel I, et al. Among authors: kremer b. Pancreatology. 2002;2(2):79-88. doi: 10.1159/000055896. Pancreatology. 2002. PMID: 12123098 Review.

5

Terminally modified oligodeoxynucleotides directed against p53 in an orthotopic xenograft model: a novel adjuvant treatment strategy for pancreatic ductal carcinoma.

Tepel J, Kruse ML, March C, Fiedler A, Kapischke M, Ketterer T, Sipos B, Kremer B, Kalthoff H. Tepel J, et al. Among authors: kremer b. Pancreas. 2004 Jan;28(1):1-12. doi: 10.1097/00006676-200401000-00001. Pancreas. 2004. PMID: 14707723

6

Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.

Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, Kalthoff H, Ungefroren H. Schniewind B, et al. Among authors: kremer b. Int J Cancer. 2004 Mar 20;109(2):182-8. doi: 10.1002/ijc.11679. Int J Cancer. 2004. PMID: 14750167

7

Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival.

Soeth E, Grigoleit U, Moellmann B, Röder C, Schniewind B, Kremer B, Kalthoff H, Vogel I. Soeth E, et al. Among authors: kremer b. J Cancer Res Clin Oncol. 2005 Oct;131(10):669-76. doi: 10.1007/s00432-005-0008-1. Epub 2005 Sep 1. J Cancer Res Clin Oncol. 2005. PMID: 16136352

8

Immunological escape mechanisms in pancreatic carcinoma.

Ungefroren H, Voss M, Bernstorff WV, Schmid A, Kremer B, Kalthoff H. Ungefroren H, et al. Among authors: kremer b. Ann N Y Acad Sci. 1999 Jun 30;880:243-51. doi: 10.1111/j.1749-6632.1999.tb09529.x. Ann N Y Acad Sci. 1999. PMID: 10415870

9

Growth inhibition of pancreatic tumor cells by modified antisense oligodeoxynucleotides.

Fiedler A, Knorre C, Franke Y, Henne-Bruns D, Kremer B, Lüttges J, Maier M, Gerster M, Bleicher K, Bayer E, Kalthoff H. Fiedler A, et al. Among authors: kremer b. Langenbecks Arch Surg. 1998 Aug;383(3-4):269-75. doi: 10.1007/s004230050131. Langenbecks Arch Surg. 1998. PMID: 9776455

10

Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by CpG oligonucleotides in immunodeficient mice.

Tepel J, Dagvadorj O, Kapischke M, Sipos B, Leins A, Kremer B, Kalthoff H. Tepel J, et al. Among authors: kremer b. Int J Colorectal Dis. 2006 May;21(4):365-72. doi: 10.1007/s00384-005-0013-5. Epub 2005 Aug 16. Int J Colorectal Dis. 2006. PMID: 16133009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters